SNRK expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.909040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.577000E-01
Normal-vs-Stage2
2.210000E-01
Normal-vs-Stage3
3.866100E-02
Normal-vs-Stage4
2.515600E-01
Stage1-vs-Stage2
9.378600E-01
Stage1-vs-Stage3
6.372400E-02
Stage1-vs-Stage4
9.743000E-01
Stage2-vs-Stage3
1.246780E-01
Stage2-vs-Stage4
9.297200E-01
Stage3-vs-Stage4
1.436040E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.505240E-01
Normal-vs-AfricanAmerican
9.128000E-01
Normal-vs-Asian
1.178040E-01
Caucasian-vs-AfricanAmerican
2.478600E-01
Caucasian-vs-Asian
2.981600E-01
AfricanAmerican-vs-Asian
7.910200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.634200E-01
Normal-vs-Female
2.425600E-01
Male-vs-Female
2.130600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.308800E-01
Normal-vs-Age(41-60Yrs)
4.600400E-01
Normal-vs-Age(61-80Yrs)
1.336420E-01
Normal-vs-Age(81-100Yrs)
1.568110E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.078390E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.574400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.866050E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.073900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.122130E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.177770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.747700E-02
Normal-vs-Daily Drinker
2.354400E-02
Normal-vs-Weekly Drinker
1.909790E-01
Normal-vs-Occasional Drinker
8.196400E-02
Normal-vs-Social Drinker
3.962200E-01
Non Drinker-vs-Daily Drinker
5.502200E-01
Non Drinker-vs-Weekly Drinker
9.369600E-01
Non Drinker-vs-Occasional Drinker
8.862200E-01
Non Drinker-vs-Social Drinker
3.560800E-01
Daily Drinker-vs-Weekly Drinker
5.954800E-01
Daily Drinker-vs-Occasional Drinker
4.713400E-01
Daily Drinker-vs-Social Drinker
2.346200E-01
Weekly Drinker-vs-Occasional Drinker
9.722600E-01
Weekly Drinker-vs-Social Drinker
5.350400E-01
Occasional Drinker-vs-Social Drinker
4.667400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.414010E-01
Normal-vs-Grade 2
4.497700E-02
Normal-vs-Grade 3
5.788300E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.126400E-01
Grade 1-vs-Grade 3
9.412200E-01
Grade 1-vs-Grade 4
1.414010E-01
Grade 2-vs-Grade 3
1.440430E-01
Grade 2-vs-Grade 4
4.497700E-02
Grade 3-vs-Grade 4
5.788300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.292640E-01
Normal-vs-NonDiabetic
1.056970E-01
Diabetic-vs-NonDiabetic
8.278400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.299700E-02
Normal-vs-NoPancreatitis
1.138600E-01
Pancreatitis-vs-NoPancreatitis
6.305000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.433630E-01
Normal-vs-N1
2.402600E-01
N0-vs-N1
1.794380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.781900E-02
Normal-vs-TP53-NonMutant
4.986200E-01
TP53-Mutant-vs-TP53-NonMutant
2.951800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
